SK Bioscience Discusses Strengthening Partnership with Bill & Melinda Gates Foundation

From the left, Choi Chang-won, Vice Chairman of SK Discovery; Trevor Mundel, Head of Global Health at the Bill & Melinda Gates Foundation; and Ahn Jae-yong, President of SK Bioscience.

[Asia Economy Reporter Lee Gwan-joo] SK Bioscience announced on the 17th that it discussed ways to strengthen its partnership with the Bill & Melinda Gates Foundation to promote public health.

The meeting was attended by Choi Chang-won, Vice Chairman of SK Discovery, Ahn Jae-yong, President of SK Bioscience, Mark Suzman, CEO, and Tremor Mundell, Head of Global Health.

Both parties agreed to address global health challenges, including SK Bioscience's COVID-19 vaccine 'Skycovione (GBP510)', and to expand cooperation to respond to various future diseases and epidemics.